Omaxe
- Market cap
- ₹ 1,795 Cr.
- P/E
- 24.8x
- 52-week range
- 62.5 – 138.89
- ROCE
- −110%
- Dividend yield
- 0%
- Sector
- Realty
- Industry
- Residential, Commercial Projects
- Listed on
- NSE, BSE
About
Omaxe Limited is an India-based company, which is engaged in the business of real estate developments. The Company operates in two geographical segments: Within India, and Outside India. It is engaged in the business of providing infrastructure facilities including housing, real estate development and more. The Company's portfolio comprises integrated and high-tech townships, group housing, SCOS, shopping malls, and hotels. Its residential properties include Royal Signature, Gardenia, The Resort, OmaxShiva Phase III, Europia Villa, Celestia Grand Premier, Omaxe Anandam, Omaxe City, Celestia Grande (Independent Floors), Omaxe Plots Mayakhedi, Omaxe Riviera Group Housing, Omaxe Waterscapes, Omaxe Heights two & three BHK, and more. The Company's commercial property includes Royal Street Sector Satara, Omaxe City Center, Omaxe Plaza Indirapuram, Omaxe Chowk, Omaxe Mall, Omaxe Gurgaon Mall, Omaxe Celebrations Mall, Omaxe SRK Mall, Beacon Street, Omaxe Royal Arcade, and others.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Residential, Commercial Projects: 174 companies →Omaxe against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)24.8 against a typical 23.3: pricier than most peers (1st = cheapest).90th of 173
- Sales growth+43.9% against a typical +6.6% from a year earlier.40th of 134
- Share price, 3 months+21% against a typical −9.9%.14th of 147
- Size₹ 1,795.3 Cr. market value against a typical ₹ 129.6 Cr. (1st = largest).38th of 163
Latest announcements
Exchange filings and their impact on the company.
- Revenue up 79% and quarterly loss shrinks from Rs 166 cr to Rs 26 cr, sharply slowing cash burn.
Omaxe reported Q2 FY27 consolidated revenue of Rs 575.5 crore, up 79% from a year ago, with net loss narrowing to Rs 25.6 crore from Rs 166.4 crore. For the half year, revenue was Rs 981.7 crore with a small loss of Rs 24.3 crore versus a Rs 352.2 crore loss last year. The improvement, aided by lower finance costs and strong operating cash flow of Rs 531 crore, helped cut borrowings, though net worth remains deeply negative and SEBI orders are still under legal review.
- Omaxe gets RERA nod to launch and sell its Mathura commercial-cum-service-apartment project.
Omaxe received U.P. RERA registration (No. UPRERAPRJ988231/10/2026) for its Commercial and Service Apartment project at Omaxe Eternity-2, Mathura, and disclosed launch date as October 17, 2026. The approval, valid till April 1, 2031, allows the company to sell, transfer and advertise the project. No project size or sales value was disclosed, so near-term financial impact is expected to be small.
- Omaxe ties up with Lemon Tree to operate 10 hotels with 4,000 keys in a Rs 4,000 crore sale-funded expansion.
Omaxe has signed an MOU with Lemon Tree Hotels' subsidiary Carnation Hotels to operate 10 hotel projects totalling 4,000 keys across Lucknow, Vrindavan, Ghaziabad, Greater Noida, Amritsar, Kaushambi and Faridabad. The 10 projects involve about Rs 4,000 crore of investment and are part of Omaxe's Rs 6,200 crore plan for 19 hotels, to be built over nine months to five years. Omaxe says it will fund construction through sales proceeds without bank loans, using its sale-led development model with Lemon Tree as brand operator.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Look closer
Rated BBB- to BB+ by 2 agencies- All agencies agree and none has raised a warning.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | CARE BB+ | Stable | 12 Oct 2026 |
| Infomerics | Withdrawn | Stable | 6 Oct 2026 |
| Acuite | ACUITE BBB- | Stable | 18 Mar 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 12 Oct 2026 | Reaffirmed | CARE BB+ | — | CARE | ₹ 80.81 Cr. | |
| 6 Oct 2026 | Withdrawn | was IVR BB+ & Withdrawn | — | Infomerics | ₹ 77.34 Cr. | |
| 18 Mar 2026 | New rating | ACUITE BBB- | — | Acuite | ₹ 80 Cr. | |
| 13 Oct 2025 | Withdrawn | was CARE BB+ | — | CARE | ₹ 110.98 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 27 Oct 2026 | Financial Results/Other business matters | To consider and approve the Un-Audited Financial Results (Standalone & Consolidated) for Quarter and Half Year ended on September 30, 2026 and other business matters. |
| 12 Aug 2026 | Financial Results/Other business matters | To consider and approve the Un-audited Financial Results ( Standalone & Consolidated) for the Quarter ended June 30, 2026 and Other Business Matters. |
| 15 May 2026 | Financial Results/Other business matters | To consider and approve the Financial Results (Standalone & Consolidated) for the quarter and financial year ended on March 31, 2026 and other business matters |
| 6 Feb 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2025 and other business matters |
| 14 Nov 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2025 and other business matters |
| 13 Aug 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 266 | 599 | 536 | 342 | 389 | 289 | 541 | 282 | 321 | 302 | 349 | 406 |
| Expenses | 333 | 637 | 682 | 493 | 613 | 416 | 647 | 452 | 490 | 457 | 550 | 399 |
| Operating Profit | −67 | −37 | −146 | −151 | −224 | −127 | −106 | −170 | −169 | −155 | −202 | 7 |
| OPM % | −25.2% | −6.2% | −27.3% | −44.3% | −57.6% | −43.9% | −19.6% | −60.1% | −52.7% | −51.4% | −57.9% | 1.8% |
| Other Income | 4 | 3 | 7 | 44 | 9 | 11 | 12 | 16 | 26 | 17 | 28 | 33 |
| Interest | 29 | 32 | 38 | 42 | 45 | 57 | 51 | 67 | 65 | 54 | 70 | 27 |
| Depreciation | 10 | 15 | 14 | 7 | 7 | 10 | 12 | 7 | 8 | 9 | 10 | 8 |
| Profit before tax | −103 | −82 | −191 | −157 | −267 | −183 | −157 | −228 | −216 | −201 | −254 | 5 |
| Tax % | −17.8% | −12.2% | −24.9% | −6.5% | −10.3% | −17.7% | −5.5% | −18.6% | −23.1% | −23.7% | −24.6% | 74.7% |
| Net Profit | −84 | −72 | −144 | −147 | −239 | −150 | −149 | −186 | −166 | −153 | −191 | 1 |
| EPS in Rs | −4.61 | −3.66 | −7.93 | −8.06 | −13.1 | −8.23 | −8.11 | −10.16 | −9.11 | −8.38 | −10.46 | 0.05 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- −1%
- 5 Years
- 21%
- 3 Years
- 17%
- TTM
- −8%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- −87%
- TTM
- 30%
- 10 Years
- −4%
- 5 Years
- 7%
- 3 Years
- 30%
- TTM
- —
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
Peers
Listed companies in the same business.
| Omaxe | ₹ 97.40 | ₹ 1,795 Cr. | 24.8x | — | — | — |
| DLF | ₹ 653.55 | ₹ 1,61,774 Cr. | 39x | 3.6x | 10% | 32% |
| Lodha Developers | ₹ 963.00 | ₹ 1,01,441 Cr. | 33.7x | 5.1x | 15.8% | 20.6% |
| Indus Towers | ₹ 380.00 | ₹ 1,00,250 Cr. | 14.9x | 2.7x | 19.8% | 22% |
| Oberoi Realty | ₹ 1,587.20 | ₹ 57,846 Cr. | 27.3x | 3.8x | — | 41.6% |
| Godrej Properties | ₹ 1,497.90 | ₹ 45,121 Cr. | 166x | 3.3x | 10.2% | 35.9% |
Management
- Rohtas Goel
- Whole-Time Chairman of the Board
- Atul Banshal
- Chief Financial Officer, Director-Finance
- Deshabandhu Rajesh Srikanta
- Compliance Officer, Company Secretary
- Mohit Goel
- Managing Director, Whole Time Director
- Vinit Goyal
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.